Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Evotec SE

Start price
Target price
Perf. (%)
€9.81
06.07.24
€10.00
06.07.25
-32.77%
02.09.24

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Valuable balance sheet
Traumtanz 
06.07.24 50%
buy
Halozyme Therapeutics Inc.

Start price
Target price
Perf. (%)
€39.49
31.08.23
€55.34
31.08.24
46.16%
01.09.24

HC Wainwright 
31.08.23 50%
buy
Neurocrine Bioscience

Start price
Target price
Perf. (%)
€111.30
28.08.24
-
28.08.25
4.27%
31.08.24

Could be worthwhile Investment >10% per year
daimler1 
28.08.24 50%
buy
Viatris Inc.

Start price
Target price
Perf. (%)
€10.00
31.08.23
-
31.08.24
8.41%
31.08.24

Finanzoo 
31.08.23 50%
buy
Evotec SE

Start price
Target price
Perf. (%)
€5.76
20.08.24
-
20.08.25
15.81%
29.08.24

Risky Investment
Revenue decline/stagnation expected
robertinio 
20.08.24 100%
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€177.00
28.08.23
€249.78
28.08.24
46.16%
29.08.24

Royal Bank of Canada 
28.08.23 50%
sell
Xencor Inc.

Start price
Target price
Perf. (%)
€20.60
26.08.23
-
26.08.24
-25.24%
27.08.24

StockNews.com 
26.08.23 50%
sell
Evotec SE

Start price
Target price
Perf. (%)
€13.43
15.02.24
-
15.02.25
-56.11%
26.08.24

DirectorDealer 
15.02.24 50%
buy
Exelixis Inc.

Start price
Target price
Perf. (%)
€19.85
22.08.23
€26.69
22.08.24
18.87%
23.08.24

Oppenheimer Holdings Inc. 
22.08.23 50%
sell
Sage Therapeutics Inc.

Start price
Target price
Perf. (%)
€18.10
20.08.23
-
20.08.24
-58.06%
21.08.24

StockNews.com 
20.08.23 50%
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€171.20
18.08.23
€248.29
18.08.24
40.77%
19.08.24

Royal Bank of Canada 
18.08.23 50%
buy
Sage Therapeutics Inc.

Start price
Target price
Perf. (%)
€44.20
24.06.23
€60.00
31.12.25
-83.14%
19.08.24

Could be very worthwhile Investment >20% year
BiotechBee 
24.06.23 60%
sell
Emergent Biosolutions Inc.

Start price
Target price
Perf. (%)
€2.01
02.04.24
-
02.04.25
442.04%
17.08.24

Probably not worthwhile Investment
Higher risks for its business
Lokrim 
02.04.24 20%
buy
Iovance Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€6.53
16.08.23
€26.61
16.08.24
46.63%
17.08.24

Chardan Capital 
16.08.23 50%
buy
PTC Therapeutics Inc.

Start price
Target price
Perf. (%)
€36.60
16.08.23
€59.68
16.08.24
-20.77%
17.08.24

Truist Financial Co. 
16.08.23 50%
buy
Viatris Inc.

Start price
Target price
Perf. (%)
€10.76
11.08.24
€12.50
11.08.25
-2.65%
17.08.24

AI_PennyPincher 
11.08.24 50%
buy
Halozyme Therapeutics Inc.

Start price
Target price
Perf. (%)
€40.00
15.08.23
€54.92
15.08.24
35.00%
16.08.24

HC Wainwright 
15.08.23 50%
sell
Sage Therapeutics Inc.

Start price
Target price
Perf. (%)
€20.40
12.08.23
-
12.08.24
-63.58%
13.08.24

StockNews.com 
12.08.23 50%
buy
Jazz Pharmaceuticals plc

Start price
Target price
Perf. (%)
€127.30
11.08.23
€185.95
11.08.24
-20.23%
12.08.24

HC Wainwright 
11.08.23 50%
buy
Charles River Labs Intl

Start price
Target price
Perf. (%)
€198.20
10.08.23
€227.00
10.08.24
-7.39%
11.08.24

JPMorgan Chase & Co. 
10.08.23 50%
buy
Jazz Pharmaceuticals plc

Start price
Target price
Perf. (%)
€123.15
10.08.23
€182.37
10.08.24
-17.54%
11.08.24

Royal Bank of Canada 
10.08.23 50%
buy
Halozyme Therapeutics Inc.

Start price
Target price
Perf. (%)
€40.11
10.08.23
€55.35
10.08.24
26.55%
11.08.24

Morgan Stanley 
10.08.23 50%
buy
Iovance Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€6.49
10.08.23
€34.45
10.08.24
40.01%
11.08.24

HC Wainwright 
10.08.23 50%
buy
Arrowhead Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€26.39
10.08.23
€81.59
10.08.24
-19.40%
11.08.24

HC Wainwright 
10.08.23 50%
buy
Iovance Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€6.49
10.08.23
€26.26
10.08.24
40.01%
11.08.24

Chardan Capital 
10.08.23 50%